Bactericidal activity of three β-lactams alone or in combination with a β-lactamase inhibitor and two aminoglycosides against Klebsiella pneumoniae harboring extended-spectrum β-lactamases
- 1 October 1998
- journal article
- Published by Elsevier BV in Clinical Microbiology & Infection
- Vol. 4 (10), 570-576
- https://doi.org/10.1111/j.1469-0691.1998.tb00039.x
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Treatment failure due to extended spectrum βlactamaseJournal of Antimicrobial Chemotherapy, 1996
- Extended-spectrum plasmid-mediated -lactamasesJournal of Antimicrobial Chemotherapy, 1995
- Bactericidal effect of β-lactams and amikacin alone or in association against Klebsiella pneumoniae producing extended spectrum β-lactamaseJournal of Antimicrobial Chemotherapy, 1995
- Multiply resistant Klebsiella pneumoniae strains from two Chicago hospitals: identification of the extended-spectrum TEM-12 and TEM-10 ceftazidime-hydrolyzing beta-lactamases in a single isolateAntimicrobial Agents and Chemotherapy, 1994
- Identification of TEM-26 beta-lactamase responsible for a major outbreak of ceftazidime-resistant Klebsiella pneumoniaeAntimicrobial Agents and Chemotherapy, 1994
- Origin and impact of plasmid-mediated extended-spectrum beta-lactamasesEuropean Journal of Clinical Microbiology & Infectious Diseases, 1994
- More extended-spectrum beta-lactamasesAntimicrobial Agents and Chemotherapy, 1991
- β-Lactamase Inhibition: Therapeutic Implications in Infectious Diseases—an OverviewClinical Infectious Diseases, 1991
- Transferable resistance to third-generation cephalosporins in clinical isolates of Klebsiella pneumoniae: identification of CTX-1, a novel β-lactamaseJournal of Antimicrobial Chemotherapy, 1987
- TRANSFERABLE ENZYMATIC RESISTANCE TO THIRD-GENERATION CEPHALOSPORINS DURING NOSOCOMIAL OUTBREAK OF MULTIRESISTANT KLEBSIELLA PNEUMONIAEThe Lancet, 1987